Tag: Cancer: Misc.

Incidences of major adverse cardiovascular events, cancers higher with tofacitinib versus TNF inhibitor; criteria for noninferiority not met

Mortality rate increases with increasing sequential organ failure assessment score on admission, respiratory failure, maximum lactate level

Overall survival, progression-free survival prolonged in those receiving durvalumab versus placebo in addition to gemcitabine and cisplatin

Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years

51 percent of institutions cite decreased clinical staff availability; HCPs experiencing psychological distress, financial concerns

Guideline-nonconcordant radiotherapy given to substantial proportion of Medicare beneficiaries with metastatic cancer near the end of life

The NCCN Advisory Committee supports the strong preference for mRNA vaccines and offers guidance on the timing of vaccination

During 2014 to 2018, incidence continued to increase slowly for female breast cancer, remained stable for prostate cancer

Risk for both all-cause and cancer-specific death increased for cancer survivors with combination of prolonged sitting and inactivity

High psychological distress tied to lower quality of life, social isolation, impaired cancer care